CSTL
Castle Biosciences·NASDAQ
--
--(--)
--
--(--)
6.05 / 10
Outperform
Analyst sentiment is strongly bullish: one Buy recommendation (100%) and an Outperform sentiment rating. Fund‑flow score is good (7.71), yet all size categories show negative inflow trends, indicating recent capital outflows despite positive analyst views.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Catherine Ramsey SchulteBuy
Date2026-02-27
InstitutionBaird
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of CSTL?
- CSTL holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.05/10 (Outperform).
